Abstract

Cholera toxin (CT) travels from the cell surface to the endoplasmic reticulum (ER) as an AB holotoxin. ER-specific conditions then promote the dissociation of the catalytic CTA1 subunit from the rest of the toxin. CTA1 is held in a stable conformation by its assembly in the CT holotoxin, but the dissociated CTA1 subunit is an unstable protein that spontaneously assumes a disordered state at physiological temperature. This unfolding event triggers the ER-to-cytosol translocation of CTA1 through the quality control mechanism of ER-associated degradation. The translocated pool of CTA1 must regain a folded, active structure to modify its G protein target which is located in lipid rafts at the cytoplasmic face of the plasma membrane. Here, we report that lipid rafts place disordered CTA1 in a functional conformation. The hydrophobic C-terminal domain of CTA1 is essential for binding to the plasma membrane and lipid rafts. These interactions inhibit the temperature-induced unfolding of CTA1. Moreover, lipid rafts could promote a gain of structure in the disordered, 37 °C conformation of CTA1. This gain of structure corresponded to a gain of function: whereas CTA1 by itself exhibited minimal in vitro activity at 37 °C, exposure to lipid rafts resulted in substantial toxin activity at 37 °C. In vivo, the disruption of lipid rafts with filipin substantially reduced the activity of cytosolic CTA1. Lipid rafts thus exhibit a chaperone-like function that returns disordered CTA1 to an active state and is required for the optimal in vivo activity of CTA1.

Highlights

  • Cholera toxin enters the target cell in a disordered state and must attain a folded, active conformation to modify its G protein target

  • CTA1 was incubated at 37 °C with Large Unilamellar Vesicles (LUVs) mimicking the composition of either the plasma membrane or lipid rafts (Table 1)

  • Binding of CTA1 to the pyrene-PE-containing membrane results in short range dipolar interactions between the energy donor (Trp) and the acceptor, decreasing Trp emission intensity between 300 and 360 nm and increasing the 360 – 450 nm emission intensity of pyrene-PE. This fluorescence resonance energy transfer (FRET) effect was observed when CTA1 was mixed with vesicles mimicking either the plasma membrane (Fig. 1A) or lipid rafts (Fig. 1B)

Read more

Summary

Background

Cholera toxin enters the target cell in a disordered state and must attain a folded, active conformation to modify its G protein target. CTA1 is held in a stable conformation by its assembly in the CT holotoxin, but the dissociated CTA1 subunit is an unstable protein that spontaneously assumes a disordered state at physiological temperature This unfolding event triggers the ER-to-cytosol translocation of CTA1 through the quality control mechanism of ER-associated degradation. 2 The abbreviations used are: CT, cholera toxin; ARF, ADP-ribosylation factor; ␤2AR, ␤2-adrenergic receptor; DEA-BAG, diethylamino(benzylidineamino)guanidine; ER, endoplasmic reticulum; ERAD, ER-associated degradation; LUV, large unilamellar vesicle; PE, phosphatidylethanolamine; PS, phosphatidylserine. It is possible that other host factors assist the in vivo gain of structure and gain of function for cytosolic CTA1

A Chaperone-like Activity for Lipid Rafts
EXPERIMENTAL PROCEDURES
RESULTS
34 Ϯ 1 37 Ϯ 1 44 Ϯ 1 41 Ϯ 1
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call